Prophage induction in lysogenic Aggregatibacter actinomycetemcomitans cells co-cultured with human gingival fibroblasts, and its effect on leukotoxin release

Microbial Pathogenesis

Volumn 54, Issue 1, 2013, Pages 54-59

  Stevens, Roy H ^a   Moura Martins Lobo dos Santos, Caroline de ^b   Zuanazzi, David ^c   Accioly Mattos, Marcelo Barbosas de ^a,c   Ferreira, Davis Fernandes ^c   Kachlany, Scott C ^d   Tinoco, Eduardo M B ^b  

^a TEMPLE UNIVERSITY   (United States)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Aggregatibacter actinomycetemcomitans; Bacteriophage; Induction; Leukotoxin; Lysogeny

Indexed keywords

LEUKOTOXIN;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ARTICLE; BACTERIAL CELL; BACTERIUM CULTURE; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; FIBROBLAST; GINGIVA; HUMAN; HUMAN CELL; LYSOGENIZATION; NONHUMAN; PRIORITY JOURNAL; PROPHAGE; TOXIN SYNTHESIS; VIRUS INDUCTION;

BACTERIOPHAGES; CELLS, CULTURED; COCULTURE TECHNIQUES; EPITHELIAL CELLS; EXOTOXINS; FIBROBLASTS; HOST-PATHOGEN INTERACTIONS; HUMANS; LYSOGENY; PASTEURELLACEAE; VIRUS ACTIVATION;

BACTERIA (MICROORGANISMS);

EID: 84871167303     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2012.09.005     Document Type: Article

References (55)

1. Stevens R.H., Hammond B.F., Lai C.H. Characterization of an inducible bacteriophage from a leukotoxic strain of Actinobacillus actinomycetemcomitans. Infect Immun 1982, 35:343-349.
2. Stevens R.H., Preus H.R., Dokko B., Russell D., Fine D.H., Figurski D.H., et al. The prevalence and distribution of bacteriophage φAa infection in strains of Actinobacillus actinomycetemcomitans. FEMS Microbiol Lett 1994, 119(3):329-338.
3. Loftus A., Delisle A.L. Inducible bacteriophages of Actinobacillus actinomycetemcomitans. Curr Microbiol 1995, 30:317-321.
4. Sandmeier H., van Winkelhoff A.J., Bar K., Ankli E., Maeder M., Meyer J. Temperate bacteriophages are common among Actinobacillus actinomycetemcomitans isolates from periodontal pockets. J Periodont Res 1995, 30:418-425.
5. Tinoco E.M.B., Stevens R.H., Haubek D., Lai C.-H., Balachandran S., Preus H. Relationship of serotype, leukotoxin gene type and lysogeny in Actinobacillus actinomycetemcomitans to periodontal disease. Eur J Oral Sci 1997, 105:310-317.
6. Willi K., Sandmeier H., Asikaninen S., Saarela M., Meyer J. Occurrence of temperate bacteriophages in different Actinobacillus actinomycetemcomitans serotypes isolated from periodontally healthy individuals. Oral Microbiol Immunol 1997, 12:40-46.
7. Wagner P.L., Waldor M.K. Bacteriophage control of bacterial virulence. Infect Immun 2002, 70(8):3985-3993.
8. Boyd E.F., Brüssow H. Common themes among bacteriophage-encoded virulence factors and diversity among the bacteriophages involved. Trends Microbiol 2002, 10(11):521-529.
9. Phages: their role in bacterial pathogenesis and biotechnology 2005, ASM Press, Washington DC. M.K. Waldor, D.I. Friedeman, S.L. Adhya (Eds.).
10. Gemski P., O'Brien A., Wohlhieter J. Cellular release of heat-labile enterotoxin of Escherichia coli by bacteriophage induction. Infect Immun 1978, 9:1076-1082.
11. Houston C., Koo F., Peterson J. Characterization of toxin released by mitomycin C-treated cells. Infect Immun 1981, 32:916-926.
12. Peterson J.W., Houston C., Koo F. Influence of cultural conditions on mitomycin C-mediated bacteriophage induction and release of Salmonella toxin. Infect Immun 1981, 32:232-242.
13. Wagner P.L., Livny J., Neely M.N., Acheson D.W.K., Friedman D.I., Waldor M.K. Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol Microbiol 2002, 44:957-970.
14. Zabriskie J.B. The role of temperate bacteriophage in the production of erythrogenic toxin by group A streptococci. J Exp Med 1964, 119:761-779.
15. Banks D.J., Lei B., Musser J.M. Prophage induction and expression of prophage-encoded virulence factors in group A Streptococcus serotype M3 strain MGAS315. Infect Immun 2003, 71(12):7079-7086.
16. Broudy T.B., Pancholi V., Fischetti V.A. The in Vitro interaction of Streptococcus pyogenes with human pharyngeal cells induces a phage-encoded extracellular DNAse. Infect Immun 2002, 70(6):2805-2811.
17. Bensing B.A., Siboo I.R., Sullam P.M. Proteins PblA and PblB of Streptococcus mitis, which promote binding to human platelets, are encoded within a lysogenic bacteriophage. Infect Immun 2001, 69:6186-6192.
18. Figueroa-Bossi N., Bossi L. Inducible prophages contribute to Salmonella virulence in mice. Mol Microbiol 1999, 33:167-176.
19. Los J.M., Los M., Wegrzyn G., Wegrzyn A. Differential efficiency of induction of various lambdoid prophages responsible for production of Shiga toxins in response to different induction agents. Microb Pathogenesis 2009, 47:289-298.
20. Broudy T.B., Pancholi V.P., Fischetti V.A. Induction of lysogenic bacteriophage and phage-associated toxin from group A streptococci during coculture with human pharyngeal cells. Infect Immun 2001, 69(3):1440-1443.
21. Baehni P.C., Tsai C.-C., McArthur W.P., Hammond B.F., Taichman N.S. Interaction of inflammatory cells and oral microorganisms. VIII. Detection of leukotoxic activity of a plaque-derived Gram-negative microorganism. Infect Immun 1979, 24:233-243.
22. Tsai C.-C., McArthur W.P., Baehi P.C., Hammond B.F., Taichman N.S. Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism. Infect Immun 1979, 25:427-439.
23. Sugai M., Kawamot T., Peres S.Y., Ueno Y., Komatsuzawa H., Fujiwara T., et al. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 1998, 66(10):5008-5019.
24. Kiley P., Holt S.C. Characterization of the lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4 and N27. Infect Immun 1980, 30(3):862-873.
25. Meyer D.H., Sreenivasan P.K., Fives-Taylor P.M. Evidence for invasion of a human oral cell line by Actinobacillus actinomycetemcomitans. Infect Immun 1991, 59(8):2719-2726.
26. Meyer D.H., Lippmann J.E., Fives-Taylor P.M. Invasion of epithelial cells by Actinobacillus actinomycetemcomitans: a dynamic, multistep process. Infect Immun 1996, 64:2988-2992.
27. Rudney J.D., Chen R., Sedgewick G.J. Intracellular Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in buccal epithelial cells collected from human subjects. Infect Immun 2001, 69:2700-2707.
28. Saglie F.R., Carranza F.A., Newman M.G., Chenng L., Lewin K.J. Identification of tissue-invading bacteria in human periodontal disease. J Periodont Res 1982, 17:452-455.
29. ChristerssonLA Albini B., Zambon J.J., Wikesjö U.M.E., Geno R.J. Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitits. I. Light, immunofluorescence, and electron microscopic studies. J Periodontol 1987, 58:529-539.
30. Chen C., Goodman S.D. Spontaneously released bacteriophage from Actinobacillus actinomycetemcomitans. J Dent Res 1995, 74:197. AADR Abstracts, Abstr. 1486.
31. Livny J., Friedman D.I. Characterizing spontaneous induction of Stx encoding phages using a selectable reporter system. Mol Microbiol 2004, 51(6):1691-1704.
32. Wagner P.L., Acheson D.W.K., Waldor M.K. Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli. Infect Immun 2001, 69(3):1934-1937.
33. Benchetrit L.C., Gray E.D., Edstrom R.D., Wannamaker L.W. Purification and characterization of a hyaluronidase associated with a temperate bacteriophage of group A, type 49 streptococci. J Bacteriol 1978, 134(1):221-228.
34. Halperin S.A., Ferrieri P., Gray E.D., Kaplan E.L., Wannamaker L.W. Antibody response to bacteriophage hyaluronidase in acute glomerulonephritis after group A streptococcal infection. J Infect Dis 1987, 155(2):253-261.
35. Mekalanos J.J. Environmental signals controlling expression of virulence determinants. J Bacteriol 1992, 174(1):1-7.
36. Mahan M.J., Slauch J.M., Mekalanos J.J. Selection of bacterial virulence genes that are specifically induced in host tissues. Science 1993, 259(5059):686-688.
37. Mahan M.J., Slauch J.M., Hanna P.C., Camilli A., Tobias J.W., Waldor M.K., et al. Selection for bacterial genes that are specifically induced in host tissues: the hunt for virulence factors. Infect Agents Dis 1993, 2(4):263-268.
38. Slauch J.M., Mahan M.J., Mekalanos J.J. In vivo expression technology for selection of bacterial genes specifically induced in host tissues. Methods Enzymol 1994, 235:481-492.
39. Cotter P.A., Miller J.F. In vivo and ex vivo regulation of bacterial virulence gene expression. Curr Opin Microbiol 1998, 1(1):17-26.
40. Song Y.-H., Kozarov E.V., Wlaters S.M., Cao S.L., Handfield M., Hilllman J.D., et al. Genes of periodontopathogens expressed during human disease. Ann Periodontol 2002, 7(1):38-42.
41. Cao S.L., Progulske-Fos A., Hillman J.D., Handfield M. In vivo induced antigenic determinants of Actinobacillus actinomycetemcomitans. FEMS Microbiol Lett 2004, 237:97-103.
42. Handfield M., Progulske-Fox A., Hillman J.D. In vivo induced genes in human diseases. Periodontol 2000 2005, 38:123-134.
43. Stevens R., Matto M., Tinoco E., Buttaro B., Utter B., Fernandes Ferreira D. Antibody response against Aggregatibacter actinomycetemcomitans bacteriophage φAa among Brazilian individuals. J Dent Res 2012, 91(B). Abstr 0214.
44. Baehni P.C., Tsai C.-C., McArthur W.P., Hammond B.F., Shenker B.J., Taichman N.S. Leukotoxic activity in different strains of the bacterium Actinobacillus actinomycetemcomitans isolated from juvenile periodontitis in man. Arch Oral Biol 1981, 26:671-676.
45. Tsai C.-C., Shenker B.J., DiRienzo J.M., Malamud D., Taichman N.S. Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B. Infect Immun 1984, 43:700-705.
46. Zambon J.J., DeLuca C., Slots J., Genco R. Studies of leukotoxin from Actinobacillus actinomycetemcomitans using the promyelocytic HL-60 cell line. Infect Immun 1983, 40(1):205-212.
47. DiRienzo J.M., Tsai C.-C., Shenker B.J., Taichman N.S., Lally E.T. Monoclonal antibodies to leukotoxin of Actinobacillus actinomycetemcomitans. Infect Immun 1985, 47:31-36.
48. Ohta H., Kokeguchi S., Fukui K., Kato K. Leukotoxic activity in Actinobacillus (Haemophilus) actinomycetemcomitans isolated from periodontal disease patients. Microbiol Immunol 1987, 31:313-325.
49. Lally E.T., Golub E.E., Kieba I.R., Taichman N.S., Decker S., Berhold P., et al. Structure and function of the B and D genes of the Actinobacillus actinomycetemcomitans leukotoxin complex. Microb Pathogenesis 1991, 11:111-121.
50. Ohta H., Kato K., Kokeguchi S., Hara H., Fukui K., Murayama Y. Nuclease-sensitive binding of Actinobacillus actinomycetemcomitans leukotoxin to the bacterial cell surface. Infect Immun 1991, 59(12):4599-4605.
51. Berthold P., Forti D., Kieba I.R., Rosenbloom J., Taichman N.S., Lally E.T. Electron immunocytochemical localization of Actinobacillus actinomycetemcomitans leukotoxin. Oral Microbiol Immunol 1992, 7:24-27.
52. Johansson A., Claesson R., Hanstrom L., Kalfas S. Serum-mediated release of leukotoxin from the cell surface of the periodontal pathogen Actinobacillus actinomycetemcomitans. Eur J Oral Sci 2003, 111(3):209-215.
53. Kachlany S.C., Fine D.H., Figurski D.H. Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans. Infect Immun 2000, 68(11):6094-6100.
54. Kachlany S.C. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy. J Dent Res 2010, 89(6):561-570.
55. Stevens R., Goncharoff P., Furgang D., Fine D., Schreiner H., Figurski D. Characterization and physical mapping of the genome of bacteriophage ØAa from Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 1993, 8(2):100-104.